AstraZeneca jumps as tozorakimab hits primary goals in two phase III COPD trials, cuts exacerbations and shows promise in a ...

Bristol Myers Squibb is adding three prescription medications on TrumpRx.gov on Monday, offering discounts of up to 90%, FOX ...

The rate of new chronic obstructive pulmonary disease (COPD) cases decreased from 2001 to 2020, although the prevalence of ...

Alto Neurosciences is halting work on its schizophrenia prospect after the brain-penetrant drug flunked a phase 2 study. The Bay Area biotech evaluated 10 days of treatment with t ...

Toby Keeton, who set an all-time single-season earnings record for U.S. Quarter Horse trainers in 2024, has been suspended ...

Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to ...

Insmed remains a Buy, with an enterprise value near $30B and robust growth driven by Brinsupri and pipeline assets. Learn ...

The drug and biotech sector has been in a recovery mode since mid-2025, after going through a difficult period between 2021 ...

CHIANG RAI - Health Ministry data lists Chiang Rai as among the top 10 provinces with the highest PM2.5 dust pollution. Health Department data shows it in the ...

Select your location to view local American Lung Association events and news near you.

The eye drops — sold under multiple brands — have been recalled over concerns about sterility, according to the FDA.

The U.S. Food and Drug Administration has approved Eli Lilly's oral weight-loss drug, orforglipron, branded as Foundayo, ...